Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Inivata
company
About
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.
- 51 - 100
Details
- Last Funding Type
- Corporate Round
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Genetics,Health Care,Medical Device
- Founded date
- Jan 1, 2014
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis to improve testing and treatment for oncologists and their patients.Unlike conventional invasive biopsies, Inivata detects and analyses genomic material from a cancer patient’s cell-free, circulating tumor DNA (ctDNA) which can be collected through a simple blood sample. This non-invasive approach – a liquid biopsy – offers a revolution in how cancer is detected, monitored, and treated.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$77.60M £35.50M
Inivata has raised a total of
$77.60M £35.50M
in funding over 2 rounds. Their latest funding was raised on
May 26, 2020 from a Corporate Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 26, 2020 | Corporate Round | $25M | 1 |
NeoGenomics
|
— | Detail |
| Mar 28, 2019 | Series B | $52.60M | 1 | — | — | Detail |
| Jan 26, 2016 | Series A | £31.50M | 1 | — | — | Detail |
| Sep 23, 2014 | Series Unknown | £4M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Inivata is funded by 2 investors.
NeoGenomics
and Cambridge Innovation Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
NeoGenomics
|
Yes | Corporate Round |
Cambridge Innovation Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
